1OT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ovid Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.95 EUR -3.47% Market Closed

Market Cap: €138.1m

O	Ovid Therapeutics Inc F:1OT	US
	MPC Energy Solutions NV F:5IX	NL
B	Brembo SpA SWB:BRCA	IT

Profitability Summary

Ovid Therapeutics Inc's profitability score is 18/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-670%

Negative 3Y Average Operating Margin

-8.412%

Operating Margin is Increasing

-27.050% > -670%

Negative Net Margin

-339%

Negative 3Y Average Net Margin

-5.576%

Net Margin is Increasing

-24.650% > -339%

Negative Free Cash Flow Margin

-589%

Negative 3Y Average Free Cash Flow Margin

-6.944%

Free Cash Flow Margin is Increasing

-22.900% > -589%

Negative ROE

-19%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-152%

ROIC is Increasing

-193% > -97%

View All

Hide

Collapse

18 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.